Celera Corporation (Celera), an in vitro diagnostics company, announced that its chief financial officer (CFO), Joel Jung, has resigned from the company to pursue other opportunities. Celera has appointed Ugo DeBlasi as its new CFO of the company, effective April 06, 2009. In this position, DeBlasi will provide leadership to the Celera finance, investor relations and information technology function, and he will report to Kathy Ordonez, Celera’s chief executive officer.
DeBlasi previously worked for Applera Corporation. He served as the chief accounting officer for a total of eight years during his tenure with Applera. For the last five years, he held the position of vice president and controller reporting to the CFO. DeBlasi also held the positions of vice president, Celera Genomics; corporate controller; assistant corporate controller; director financial accounting and reporting; and senior manager, financial reporting. Prior to Applera, DeBlasi worked as a senior auditor for Price Waterhouse.
DeBlasi earned his Bachelor of Science in Accounting from Boston College in 1984 and is a licensed Certified Public Accountant.
“I am delighted that Ugo has joined us as Chief Financial Officer and look forward to making use of his exceptional financial and leadership skills, as well as the knowledge of our business he gained by working with us closely for many years in the past,” said. Ordonez.
“We appreciate Joel’s contributions since joining our team nearly three years ago, and we wish him well in his future endeavors,” Ordonez added.